NDC11 66658023101
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 66658-0231-01 | 66658-0231 |
| 66658-0231-1 | 66658-0231 |
| 66658-231-01 | 66658-231 |
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 66658-231 | 66658-231-01 | D | Discontinued by firm | 2026-08-17 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Synagis | PALIVIZUMAB | Swedish Orphan Biovitrum AB (publ) | 3a0096c7-8139-44cd-bba4-520ab05c2cb2 | 2026-01-21 | Warnings, Adverse reactions | 66658-231-01 66658-231 66658023101 |